| ■ 영문 제목 : Global Hypercholesterolemia Treatment Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00141 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 고콜레스테롤혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (AEM-2802, AEM-2814, 아릴로쿠맙, 에비나쿠맙, 기타)와 용도별 시장규모 (클리닉, 병원, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 고콜레스테롤혈증 치료 시장 점유율 - 지역별 고콜레스테롤혈증 치료 시장규모 - 주요지역의 종류별 시장규모 (AEM-2802, AEM-2814, 아릴로쿠맙, 에비나쿠맙, 기타) - 주요지역의 용도별 시장규모 (클리닉, 병원, 기타) - 미주의 고콜레스테롤혈증 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 고콜레스테롤혈증 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 고콜레스테롤혈증 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 고콜레스테롤혈증 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 고콜레스테롤혈증 치료 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc, The Medicines Company - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Hypercholesterolemia Treatment will have significant change from previous year. By the most conservative estimates of global Hypercholesterolemia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hypercholesterolemia Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Hypercholesterolemia Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Clinic
Hospital
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company
1 Scope of the Report 2 Executive Summary 3 Hypercholesterolemia Treatment Market Size by Players 4 Hypercholesterolemia Treatment by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Hypercholesterolemia Treatment Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Hypercholesterolemia Treatment Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of AEM-2802 Table 3. Major Players of AEM-2814 Table 4. Major Players of Alirocumab Table 5. Major Players of Evinacumab Table 6. Major Players of Others Table 7. Hypercholesterolemia Treatment Market Size CAGR by Type (2020-2026) & ($ Millions) Table 8. Global Hypercholesterolemia Treatment Market Size by Type (2016-2021) & ($ Millions) Table 9. Global Hypercholesterolemia Treatment Market Size Market Share by Type (2016-2021) Table 10. Hypercholesterolemia Treatment Market Size CAGR by Application (2016-2021) & ($ Millions) Table 11. Global Hypercholesterolemia Treatment Market Size by Application (2016-2021) & ($ Millions) Table 12. Global Hypercholesterolemia Treatment Market Size Market Share by Application (2016-2021) Table 13. Global Hypercholesterolemia Treatment Revenue by Players (2019-2021E) & ($ Millions) Table 14. Global Hypercholesterolemia Treatment Revenue Market Share by Players (2019-2021E) Table 15. Hypercholesterolemia Treatment Key Players Head office and Products Offered Table 16. Hypercholesterolemia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Hypercholesterolemia Treatment Market Size by Regions 2016-2021 & ($ Millions) Table 20. Global Hypercholesterolemia Treatment Market Size Market Share by Regions 2016-2021 Table 21. Americas Hypercholesterolemia Treatment Market Size by Country (2016-2021) & ($ Millions) Table 22. Americas Hypercholesterolemia Treatment Market Size Market Share by Country (2016-2021) Table 23. Americas Hypercholesterolemia Treatment Market Size by Type (2016-2021) & ($ Millions) Table 24. Americas Hypercholesterolemia Treatment Market Size Market Share by Type (2016-2021) Table 25. Americas Hypercholesterolemia Treatment Market Size by Application (2016-2021) & ($ Millions) Table 26. Americas Hypercholesterolemia Treatment Market Size Market Share by Application (2016-2021) Table 27. APAC Hypercholesterolemia Treatment Market Size by Region (2016-2021) & ($ Millions) Table 28. APAC Hypercholesterolemia Treatment Market Size Market Share by Region (2016-2021) Table 29. APAC Hypercholesterolemia Treatment Market Size by Type (2016-2021) & ($ Millions) Table 30. APAC Hypercholesterolemia Treatment Market Size Market Share by Type (2016-2021) Table 31. APAC Hypercholesterolemia Treatment Market Size by Application (2016-2021) & ($ Millions) Table 32. APAC Hypercholesterolemia Treatment Market Size Market Share by Application (2016-2021) Table 33. Europe Hypercholesterolemia Treatment Market Size by Country (2016-2021) & ($ Millions) Table 34. Europe Hypercholesterolemia Treatment Market Size Market Share by Country (2016-2021) Table 35. Europe Hypercholesterolemia Treatment Market Size by Type (2016-2021) & ($ Millions) Table 36. Europe Hypercholesterolemia Treatment Market Size Market Share by Type (2016-2021) Table 37. Europe Hypercholesterolemia Treatment Market Size by Application (2016-2021) & ($ Millions) Table 38. Europe Hypercholesterolemia Treatment Market Size Market Share by Application (2016-2021) Table 39. Middle East & Africa Hypercholesterolemia Treatment Market Size by Region (2016-2021) & ($ Millions) Table 40. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Region (2016-2021) Table 41. Middle East & Africa Hypercholesterolemia Treatment Market Size by Type (2016-2021) & ($ Millions) Table 42. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Type (2016-2021) Table 43. Middle East & Africa Hypercholesterolemia Treatment Market Size by Application (2016-2021) & ($ Millions) Table 44. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Application (2016-2021) Table 45. Key and Potential Regions of Hypercholesterolemia Treatment Table 46. Key Application and Potential Industries of Hypercholesterolemia Treatment Table 47. Key Challenges of Hypercholesterolemia Treatment Table 48. Key Trends of Hypercholesterolemia Treatment Table 49. Global Hypercholesterolemia Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 50. Global Hypercholesterolemia Treatment Market Size Market Share Forecast by Regions (2021-2026) Table 51. Global Hypercholesterolemia Treatment Market Size Forecast by Type (2021-2026) & ($ Millions) Table 52. Global Hypercholesterolemia Treatment Market Size Market Share Forecast by Type (2021-2026) Table 53. Global Hypercholesterolemia Treatment Market Size Forecast by Application (2021-2026) & ($ Millions) Table 54. Global Hypercholesterolemia Treatment Market Size Market Share Forecast by Application (2021-2026) Table 55. CymaBay Therapeutics Inc Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 56. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Product Offered Table 57. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 58. CymaBay Therapeutics Inc Main Business Table 59. CymaBay Therapeutics Inc Latest Developments Table 60. Daewoong Co Ltd Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 61. Daewoong Co Ltd Hypercholesterolemia Treatment Product Offered Table 62. Daewoong Co Ltd Main Business Table 63. Daewoong Co Ltd Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 64. Daewoong Co Ltd Latest Developments Table 65. Gemphire Therapeutics Inc Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 66. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Product Offered Table 67. Gemphire Therapeutics Inc Main Business Table 68. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. Gemphire Therapeutics Inc Latest Developments Table 70. LipimetiX Development Inc Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 71. LipimetiX Development Inc Hypercholesterolemia Treatment Product Offered Table 72. LipimetiX Development Inc Main Business Table 73. LipimetiX Development Inc Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. LipimetiX Development Inc Latest Developments Table 75. Regeneron Pharmaceuticals Inc Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 76. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Product Offered Table 77. Regeneron Pharmaceuticals Inc Main Business Table 78. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. Regeneron Pharmaceuticals Inc Latest Developments Table 80. RegenxBio Inc Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 81. RegenxBio Inc Hypercholesterolemia Treatment Product Offered Table 82. RegenxBio Inc Main Business Table 83. RegenxBio Inc Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. RegenxBio Inc Latest Developments Table 85. The Medicines Company Details, Company Type, Hypercholesterolemia Treatment Area Served and Its Competitors Table 86. The Medicines Company Hypercholesterolemia Treatment Product Offered Table 87. The Medicines Company Main Business Table 88. The Medicines Company Hypercholesterolemia Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. The Medicines Company Latest Developments List of Figures Figure 1. Hypercholesterolemia Treatment Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Hypercholesterolemia Treatment Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Hypercholesterolemia Treatment Market Size Market Share by Type in 2020 Figure 7. Hypercholesterolemia Treatment in Clinic Figure 8. Global Hypercholesterolemia Treatment Market: Clinic (2016-2021) & ($ Millions) Figure 9. Hypercholesterolemia Treatment in Hospital Figure 10. Global Hypercholesterolemia Treatment Market: Hospital (2016-2021) & ($ Millions) Figure 11. Hypercholesterolemia Treatment in Others Figure 12. Global Hypercholesterolemia Treatment Market: Others (2016-2021) & ($ Millions) Figure 13. Global Hypercholesterolemia Treatment Market Size Market Share by Application in 2020 Figure 14. Global Hypercholesterolemia Treatment Revenue Market Share by Player in 2020 Figure 15. Global Hypercholesterolemia Treatment Market Size Market Share by Regions (2016-2021) Figure 16. Americas Hypercholesterolemia Treatment Market Size 2016-2021 ($ Millions) Figure 17. APAC Hypercholesterolemia Treatment Market Size 2016-2021 ($ Millions) Figure 18. Europe Hypercholesterolemia Treatment Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Hypercholesterolemia Treatment Market Size 2016-2021 ($ Millions) Figure 20. Americas Hypercholesterolemia Treatment Market Size Market Share by Country in 2020 Figure 21. Americas Hypercholesterolemia Treatment Market Size Market Share by Type in 2020 Figure 22. Americas Hypercholesterolemia Treatment Market Size Market Share by Application in 2020 Figure 23. United States Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Hypercholesterolemia Treatment Market Size Market Share by Regions in 2020 Figure 27. APAC Hypercholesterolemia Treatment Market Size Market Share by Type in 2020 Figure 28. APAC Hypercholesterolemia Treatment Market Size Market Share by Application in 2020 Figure 29. China Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 33. India Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Hypercholesterolemia Treatment Market Size Market Share by Country in 2020 Figure 36. Europe Hypercholesterolemia Treatment Market Size Market Share by Type in 2020 Figure 37. Europe Hypercholesterolemia Treatment Market Size Market Share by Application in 2020 Figure 38. Germany Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 39. France Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Hypercholesterolemia Treatment Market Size Market Share by Application in 2020 Figure 46. Egypt Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Hypercholesterolemia Treatment Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 52. APAC Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 53. Europe Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 55. United States Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 56. Canada Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 57. Mexico Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 58. Brazil Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 59. China Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 60. Japan Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 61. Korea Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 63. India Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 64. Australia Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 65. Germany Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 66. France Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 67. UK Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 68. Italy Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 69. Russia Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 70. Spain Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 71. Egypt Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 72. South Africa Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 73. Israel Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 74. Turkey Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Hypercholesterolemia Treatment Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 고콜레스테롤혈증 치료 시장예측 2021년-2026년] (코드 : LPI-2201K00141) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 고콜레스테롤혈증 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |